Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida

Autores:: Matute Mizger, Vanesa
Martínez Sánchez, Lina Maria

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_9bb9a3f7de06864095fc14b730c0b5ac
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/3093
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
dc.title.translated.eng.fl_str_mv	Chemotherapy in lymphoma and its close relation with human immunodeficiency virus /acquired immunodeficiency syndrome
title	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
spellingShingle	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA. infections lymphoma neoplasms chemotherapy AIDS serological
title_short	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
title_full	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
title_fullStr	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
title_full_unstemmed	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
title_sort	Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida
dc.creator.fl_str_mv	Matute Mizger, Vanesa Martínez Sánchez, Lina Maria
dc.contributor.author.spa.fl_str_mv	Matute Mizger, Vanesa Martínez Sánchez, Lina Maria
dc.subject.spa.fl_str_mv	Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA.
topic	Infecciones linfoma Neoplasias Quimioterapia Serodiagnóstico del SIDA. infections lymphoma neoplasms chemotherapy AIDS serological
dc.subject.eng.fl_str_mv	infections lymphoma neoplasms chemotherapy AIDS serological
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-04-06 16:33:03 2022-06-29T19:39:42Z
dc.date.issued.none.fl_str_mv	2020-04-06
dc.date.available.none.fl_str_mv	2020-04-06 16:33:03 2022-06-29T19:39:42Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREV
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/3093
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313
identifier_str_mv	0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/3093 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Wang Z, Zhang R, Liu L, Shen Y, Chen J, Qi T, et al. Incidence and spectrum of infections among HIV/AIDS patients with lymphoma during chemotherapy. J Infect Chemother. 2021; (10):1459-64. doi: 10.1016/j.jiac.2021.06.012. 2. Hernández-Ramírez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495-e504. doi: 10.1016/S2352-3018(17)30125-X. 3. Ramorola BR, Goolam-Hoosen T, Alves de Souza Rios L, Mowla S. Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis. Genes (Basel). 2021;12(9):1302. doi:10.3390/genes12091302. 4. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018;378(11):1029-1041. doi: 10.1056/NEJMra1615896. 5. Antel K, Chetty D, Oosthuizen J, Mohamed Z, Van der Vyver L, Verburgh E. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients. Pathology. 2021; 53(5):628-34. doi: 10.1016/j.pathol.2020.11.004. 6. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018; (11):1029-41. doi: 10.1056/NEJMra1615896. 7. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. 8. Re A, Cattaneo C, Rossi G. Hiv and Lymphoma: from Epidemiology to Clinical Management. Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019004. doi: 10.4084/MJHID.2019.004. 9. Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, et al. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 ;122(19):3251-62. doi: 10.1182/blood-2013-04-498964. 10. Shindiapina P, Pietrzak M, Seweryn M, McLaughlin E, Zhang X, Makowski M, et al. Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial. Front Immunol. 2021;12:700045. doi: 10.3389/fimmu.2021.700045. 11. Navarro JT, Moltó J, Tapia G, Ribera JM. Hodgkin Lymphoma in People Living with HIV. Cancers (Basel). 2021 ;13(17):4366. doi: 10.3390/cancers13174366. 12. Horner MJ, Shiels MS, Pfeiffer RM, Engels EA. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015. Clin Infect Dis. 2021;72(9):e224-e231. doi: 10.1093/cid/ciaa1016. 13. Kimani SM, Painschab MS, Horner MJ, Muchengeti M, Fedoriw Y, Shiels MS, et al. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020 ;7(9):e641-e651. doi: 10.1016/S2352-3018(20)30118-1. 14. Robbins HA, Shiels MS, Pfeiffer RM, Engels EA. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS. 2014 Mar ;28(6):881-90. doi: 10.1097/QAD.0000000000000163. 15. Strosberg C, Sagatys E. Primary anaplastic large cell lymphoma of the CNS as initial presentation of HIV infection: A case report. Human Pathology: Case reports. 2021; 24 (200493-523). 16. Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J, et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med. 2000 Sep 4;192(5):637-46. doi: 10.1084/jem.192.5.637. 17. Hanna J, Hossain GS, Kocerha J. The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019 May 16;10:478. doi: 10.3389/fgene.2019.00478. 18. Gebauer N, Witte HM, Merz H, Oschlies I, Klapper W, Caliebe A, Tharun L, Spielmann M, von Bubnoff N, Feller AC, Murga Penas EM. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood Adv. 2021:bloodadvances.2021004635. doi: 10.1182/bloodadvances.2021004635. 19. Schommers P, Gillor D, Hentrich M, Wyen C, Wolf T, Oette M, et al. Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica. 2018; 103(5):857-864. doi: 10.3324/haematol.2017.180893. 20. Casimiro LC, Mauro GP, Medici CTM, Weltman E. Survival and consolidative radiotherapy in patients living with HIV and treated for diffuse large B-cell lymphoma. Rep Pract Oncol Radiother. 2020; 25(6):956-960. doi: 10.1016/j.rpor.2020.09.004. 21. Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood. 2016; 128(8):1050-8. doi: 10.1182/blood-2015-08-664706. 22. Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005; 105(2):874-8. doi: 10.1182/blood-2004-04-1532. 23. Simonelli C, Zanussi S, Pratesi C, Rupolo M, Talamini R, Caffau C, et al. Immune Recovery After Autologous Stem Cell Transplantation Is Not Different for HIV-Infected Versus HIV-Uninfected Patients With Relapsed or Refractory Lymphoma. Clin Infect Dis. 2010; 50(12):1672–9. doi: 10.1086/652866 24. Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, et al. Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk. Bone Marrow Transplant. 2018; 53(2):228-230. doi: 10.1038/bmt.2017.230. 25. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4. 26. De Matos A, Lopes SB, Serra JE, Ferreira E, da Cunha JS. Mortality predictive factors of people living with human immunodeficiency virus and bloodstream infection. Int J Infect Dis. 2021 Sep;110:195-203. doi: 10.1016/j.ijid.2021.06.032 27. Ortega M, Almela M, Soriano A, Marco F, Martínez JA, Muñoz A, Peñarroja G, Mensa J. Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):969-76. doi: 10.1007/s10096-008-0531-5. 28. Ohmoto A, Fuji S. Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL. Blood Rev. 2021;46:100738. doi: 10.1016/j.blre.2020.100738. 29. Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, et al. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol. 2019;37(21):1790-1799. doi: 10.1200/JCO.18.01994. 30. Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018; 36(30):3043-3054. doi: 10.1200/JCO.18.00374.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2087
dc.relation.citationedition.spa.fl_str_mv	: Pre-Print
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía - 2020
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Revista Repertorio de Medicina y Cirugía - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/7f7d7919-b73b-47f6-a124-71d9121bfc74/download
bitstream.checksum.fl_str_mv	2d155f34cc1c7aba9a508b45b7d509ce
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355549659070464
spelling	Matute Mizger, Vanesac591cad631650434db92e7b3db9fa4e1300Martínez Sánchez, Lina Mariab20ba323a855a961957e9e26d1fef8883002020-04-06 16:33:032022-06-29T19:39:42Z2020-04-062020-04-06 16:33:032022-06-29T19:39:42ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludRevista Repertorio de Medicina y Cirugía - 2020info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313InfeccioneslinfomaNeoplasiasQuimioterapiaSerodiagnóstico del SIDA.infectionslymphomaneoplasmschemotherapyAIDS serologicalQuimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquiridaChemotherapy in lymphoma and its close relation with human immunodeficiency virus /acquired immunodeficiency syndromeapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_dcae04bchttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARTREVhttp://purl.org/coar/version/c_970fb48d4fbd8a850121-7372https://repositorio.fucsalud.edu.co/handle/001/30932462-991Xhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/1313spaWang Z, Zhang R, Liu L, Shen Y, Chen J, Qi T, et al. Incidence and spectrum of infections among HIV/AIDS patients with lymphoma during chemotherapy. J Infect Chemother. 2021; (10):1459-64. doi: 10.1016/j.jiac.2021.06.012. 2. Hernández-Ramírez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV. 2017;4(11):e495-e504. doi: 10.1016/S2352-3018(17)30125-X. 3. Ramorola BR, Goolam-Hoosen T, Alves de Souza Rios L, Mowla S. Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis. Genes (Basel). 2021;12(9):1302. doi:10.3390/genes12091302. 4. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018;378(11):1029-1041. doi: 10.1056/NEJMra1615896. 5. Antel K, Chetty D, Oosthuizen J, Mohamed Z, Van der Vyver L, Verburgh E. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients. Pathology. 2021; 53(5):628-34. doi: 10.1016/j.pathol.2020.11.004. 6. Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018; (11):1029-41. doi: 10.1056/NEJMra1615896. 7. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. 8. Re A, Cattaneo C, Rossi G. Hiv and Lymphoma: from Epidemiology to Clinical Management. Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019004. doi: 10.4084/MJHID.2019.004. 9. Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, et al. Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 ;122(19):3251-62. doi: 10.1182/blood-2013-04-498964. 10. Shindiapina P, Pietrzak M, Seweryn M, McLaughlin E, Zhang X, Makowski M, et al. Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial. Front Immunol. 2021;12:700045. doi: 10.3389/fimmu.2021.700045. 11. Navarro JT, Moltó J, Tapia G, Ribera JM. Hodgkin Lymphoma in People Living with HIV. Cancers (Basel). 2021 ;13(17):4366. doi: 10.3390/cancers13174366. 12. Horner MJ, Shiels MS, Pfeiffer RM, Engels EA. Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001-2015. Clin Infect Dis. 2021;72(9):e224-e231. doi: 10.1093/cid/ciaa1016. 13. Kimani SM, Painschab MS, Horner MJ, Muchengeti M, Fedoriw Y, Shiels MS, et al. Epidemiology of haematological malignancies in people living with HIV. Lancet HIV. 2020 ;7(9):e641-e651. doi: 10.1016/S2352-3018(20)30118-1. 14. Robbins HA, Shiels MS, Pfeiffer RM, Engels EA. Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS. 2014 Mar ;28(6):881-90. doi: 10.1097/QAD.0000000000000163. 15. Strosberg C, Sagatys E. Primary anaplastic large cell lymphoma of the CNS as initial presentation of HIV infection: A case report. Human Pathology: Case reports. 2021; 24 (200493-523). 16. Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J, et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med. 2000 Sep 4;192(5):637-46. doi: 10.1084/jem.192.5.637. 17. Hanna J, Hossain GS, Kocerha J. The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019 May 16;10:478. doi: 10.3389/fgene.2019.00478. 18. Gebauer N, Witte HM, Merz H, Oschlies I, Klapper W, Caliebe A, Tharun L, Spielmann M, von Bubnoff N, Feller AC, Murga Penas EM. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood Adv. 2021:bloodadvances.2021004635. doi: 10.1182/bloodadvances.2021004635. 19. Schommers P, Gillor D, Hentrich M, Wyen C, Wolf T, Oette M, et al. Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica. 2018; 103(5):857-864. doi: 10.3324/haematol.2017.180893. 20. Casimiro LC, Mauro GP, Medici CTM, Weltman E. Survival and consolidative radiotherapy in patients living with HIV and treated for diffuse large B-cell lymphoma. Rep Pract Oncol Radiother. 2020; 25(6):956-960. doi: 10.1016/j.rpor.2020.09.004. 21. Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, et al. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood. 2016; 128(8):1050-8. doi: 10.1182/blood-2015-08-664706. 22. Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N, et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood. 2005; 105(2):874-8. doi: 10.1182/blood-2004-04-1532. 23. Simonelli C, Zanussi S, Pratesi C, Rupolo M, Talamini R, Caffau C, et al. Immune Recovery After Autologous Stem Cell Transplantation Is Not Different for HIV-Infected Versus HIV-Uninfected Patients With Relapsed or Refractory Lymphoma. Clin Infect Dis. 2010; 50(12):1672–9. doi: 10.1086/652866 24. Re A, Gini G, Rupolo M, Levis A, Bandera A, Liberati AM, et al. Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk. Bone Marrow Transplant. 2018; 53(2):228-230. doi: 10.1038/bmt.2017.230. 25. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009 Apr 10;58(RR-4):1-207; quiz CE1-4. 26. De Matos A, Lopes SB, Serra JE, Ferreira E, da Cunha JS. Mortality predictive factors of people living with human immunodeficiency virus and bloodstream infection. Int J Infect Dis. 2021 Sep;110:195-203. doi: 10.1016/j.ijid.2021.06.032 27. Ortega M, Almela M, Soriano A, Marco F, Martínez JA, Muñoz A, Peñarroja G, Mensa J. Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):969-76. doi: 10.1007/s10096-008-0531-5. 28. Ohmoto A, Fuji S. Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL. Blood Rev. 2021;46:100738. doi: 10.1016/j.blre.2020.100738. 29. Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, et al. Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303. J Clin Oncol. 2019;37(21):1790-1799. doi: 10.1200/JCO.18.01994. 30. Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018; 36(30):3043-3054. doi: 10.1200/JCO.18.00374.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/1313/2087: Pre-PrintRevista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2817https://repositorio.fucsalud.edu.co/bitstreams/7f7d7919-b73b-47f6-a124-71d9121bfc74/download2d155f34cc1c7aba9a508b45b7d509ceMD51001/3093oai:repositorio.fucsalud.edu.co:001/30932024-02-02 13:08:25.916https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Repertorio de Medicina y Cirugía - 2020metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Quimioterapia en linfoma y su estrecha relación con el virus de la inmunodeficiencia humana /síndrome de inmunodeficiencia adquirida

Publicaciones similares